Ridvan Mercan

Impact of renal function on the safety of biologic and synthetic DMARDs in rheumatoid arthritis

This study aimed to evaluate treatment patterns, adverse events, and drug discontinuations associated with conventional synthetic (csDMARDs), biologic, and targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis (RA) and chronic kidney disea...